Authors


Susan Turkel, MD

Latest:

Introduction to Immunotherapy of Malignancies for Psychiatrists

There has been significant improvement in the outcome of many malignancies, which have required balancing anti-tumor immunity and immune toxicity.


Marie E. Gehle, PsyD

Latest:

The Role of Social Media in Private Practice

The challenges of using social media can be as numerous as the benefits.


Climate Psychiatry Alliance

Latest:

It Takes a Village to Take Care of a Planet

All together, right now, no matter what it takes-only this attitude can unite our response to the climate catastrophe that is the imminent consequence of our many small everyday actions.


Bridianne O’Dea, PhD

Latest:

Digital Mental Health: How to Engage With Innovation, Part 1

How safe and effective are mental health apps? What’s the impact of social media on youth? Insights here from presenters at APA 2019.


Mark Larsen, PhD

Latest:

Digital Mental Health: How to Engage With Innovation, Part 1

How safe and effective are mental health apps? What’s the impact of social media on youth? Insights here from presenters at APA 2019.


Julien Epps, PhD

Latest:

Digital Mental Health: How to Engage With Innovation, Part 2

Among the innovations presented at the 2019 APA meeting: voice analytics for detecting and monitoring mood, and smartphone and web-based passive data as a digital biomarker for mental health disorders.


Abhishek Pratap

Latest:

Digital Mental Health: How to Engage With Innovation, Part 2

Among the innovations presented at the 2019 APA meeting: voice analytics for detecting and monitoring mood, and smartphone and web-based passive data as a digital biomarker for mental health disorders.


Karen B. Rosenbaum, MD

Latest:

Nine Perfect Strangers

Microdosing at “Tranquillum House,” and its implications for real-world experimental psychopharmacology.


Daniel Morehead, MD

Latest:

Everyone Is Wrong About Benzodiazepines

An expert discusses how the risks of benzodiazepine prescribing have been exaggerated in the minds of government officials, critics, and the public at large.


Jessica Isom, MD, MPH

Latest:

Recognizing the Black Psychiatrists of Yesterday, Today, and Tomorrow

“The contributions of Black psychiatrists are essential for us achieving the work, achieving our goals, and really leaning into what we find to be our ‘why’ for why we do this work.”


Balkozar S. Adam, MD

Latest:

Black Americans’ Distrust of the COVID-19 Vaccine

A case for why psychiatrists should discuss the COVID vaccines with their patients.


Eleanor Lastrapes, MD

Latest:

The Aftermath of School Shootings

The impact of school shootings extends far beyond the directly affected school and community. What can we do to help survivors and family members?


Anca Livia Panfil, MD

Latest:

Ophelia

She was only 21. After "it" happened, I held a lecture on depression. I mentioned her at the end as a tribute. I longed for closure. More in this Portrait of a Psychiatrist.


Cornel N. Stanciu, MD, MRO

Latest:

Reducing Opioid-Involved Overdose Deaths: States’ Prevention and Response Efforts

In this journal club, a medical student and an addiction psychiatrist review a thematic analysis of successful prevention efforts in states with declining rates of opioid-related overdose deaths.


Samantha A. Gnanasegaram, MD

Latest:

Adjunctive Atypical Antipsychotics in Major Depressive Disorder: What’s the Impact?

The authors explore adjunctive treatments for MDD and their impact on overall medical costs and health care utilization.


Thomas M. Penders, MS, MD

Latest:

Medication-Assisted Treatment on a Budget: Two You Should Know

This CME discusses the opioid-like effects of loperamide and kratom and raises awareness of potential dangers associated with use.


Stephanie Liddicoat, PhD

Latest:

Strategies to Facilitate a Positive Clinical Encounter

The counseling environment is regarded within clinical literature as having an effect on a patient’s sense of well-being.


Aditya Vaidyam, MS

Latest:

Chatbots: What Are They and Why Care?

While conversational agent technology is growing rapidly, the various technologies (chatbots) might not yet be fully equipped to help patients with clinical needs.


Sidra Qadir, MD

Latest:

Treating Patients With Comorbid Anxiety and Diabetes Mellitus

Anxiety disorders are highly prevalent in the general population, particularly in those with medical illnesses such as diabetes.


Muhammad Hasnain Abbas, MD

Latest:

Treating Patients With Comorbid Anxiety and Diabetes Mellitus

Anxiety disorders are highly prevalent in the general population, particularly in those with medical illnesses such as diabetes.


Chiara Fabbri, MD, PhD

Latest:

Overcoming Treatment Resistance: Can Pharmacogenetics Help?

Pharmacogenetic testing can provide helpful guidance in the choice of treatment and should be interpreted as a decision-support tool to assist in thoughtful implementation of good clinical care.


Kimberly Mathos, DO, MPH

Latest:

The Psychiatric Assessment of People Who Are Deaf or Hard of Hearing

Hearing loss before the development of language has a major impact on communication, identity, and social development, as well as how mental health symptoms present.


Eduardo Constantino, MD

Latest:

A Rock and a Hard Place

The costs, risks, and considerations involved in treating addiction have upped the ante, as illustrated in this case.


Melissa Palmer, PharmD

Latest:

Identification, Assessment, and Clinical Management of Tardive Dyskinesia: An Update

This CME discusses what is known about the pathology of tardive dyskinesia, the risk factors for the disorder, assessment of patients with movement disorders, and diagnosis and treatment.


Austin R. Campbell, PharmD

Latest:

Identification, Assessment, and Clinical Management of Tardive Dyskinesia: An Update

This CME discusses what is known about the pathology of tardive dyskinesia, the risk factors for the disorder, assessment of patients with movement disorders, and diagnosis and treatment.


Amber Finegan, PharmD

Latest:

Identification, Assessment, and Clinical Management of Tardive Dyskinesia: An Update

This CME discusses what is known about the pathology of tardive dyskinesia, the risk factors for the disorder, assessment of patients with movement disorders, and diagnosis and treatment.


Leigh Anne Nelson, PharmD

Latest:

Identification, Assessment, and Clinical Management of Tardive Dyskinesia: An Update

This CME discusses what is known about the pathology of tardive dyskinesia, the risk factors for the disorder, assessment of patients with movement disorders, and diagnosis and treatment.


Schuyler W. Henderson, MD, MPH

Latest:

The Limits of Advocacy

Migrant children were being endangered, with potentially devastating effects on their mental health and development, and we requested policy changes.


Lauren Broderick, MD

Latest:

Battered Woman Syndrome: Is It Enough for a Not Guilty by Reason of Insanity Plea?

Today, 25 years after the Lorena Bobbitt trial, the case has gained a renewed interest. A look back shows how far we have-and haven’t-come in conceptualizing sexual violence.


Meghan Musselman, MD

Latest:

Battered Woman Syndrome: Is It Enough for a Not Guilty by Reason of Insanity Plea?

Today, 25 years after the Lorena Bobbitt trial, the case has gained a renewed interest. A look back shows how far we have-and haven’t-come in conceptualizing sexual violence.

© 2024 MJH Life Sciences

All rights reserved.